Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study.


Journal

The Lancet. Haematology
ISSN: 2352-3026
Titre abrégé: Lancet Haematol
Pays: England
ID NLM: 101643584

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 22 01 2019
revised: 14 03 2019
accepted: 15 03 2019
pubmed: 14 5 2019
medline: 31 10 2019
entrez: 14 5 2019
Statut: ppublish

Résumé

Transfusion-associated circulatory overload (TACO) is a major cause of transfusion-related morbidity and mortality in countries with well developed transfusion services. The International Society of Blood Transfusion, the International Haemovigilance Network, and AABB (formerly American Association of Blood Banks), have developed and validated a revised definition of TACO. International Haemovigilance Network-member haemovigilance systems (Australia, Austria, Denmark, Finland, Greece, India, Ireland, Italy, Japan, Malta, Netherlands, New Zealand, Norway, Slovenia, United Kingdom and United States) provided cases of respiratory complications categorised by their systems, including clinical parameters listed in the 2017 draft definition (part 1). Individual transfusion professionals were then invited to assess 24 case descriptions according to the draft definition (part 2). Positive and negative agreement and inter-rater agreement (κ) were calculated. Based on validation results, cases were reanalysed and slight adjustments made to yield the final 2018 TACO definition. In part 1, 16 (44%) of 36 haemovigilance systems provided 178 cases, including 126 TACO cases. By use of the 2018 definition, 96 (76%) of 126 cases of TACO were in positive agreement. 19 (37%) of 52 cases were recognised as non-TACO respiratory complications. In part 2 (47 experts from 20 countries), moderate all-case agreement (κ=0·43) and TACO-specific agreement (κ=0·54) were observed. Excluding cases missing some clinical information (eg, N terminal pro-brain natriuretic peptide, distinctive chest x-ray findings, and relationship with existing respiratory co-morbidities like pneumonia and chronic obstructive pulmonary disease) improved all-case agreement to κ=0·50 (moderate) and κ=0·65 (good) for TACO cases. The two-part validation exercise showed that the revised 2018 TACO surveillance case definition captures 76% of cases endorsed as TACO by participating haemovigilance systems. This definition can become the basis for internationally consistent surveillance reporting and contribute towards increased awareness and mitigation of TACO. Further research will require reporting more complete clinical information to haemovigilance systems and should focus on improved distinction between TACO and other transfusion respiratory complications. International Society of Blood Transfusion, International Haemovigilance Network, and AABB.

Sections du résumé

BACKGROUND BACKGROUND
Transfusion-associated circulatory overload (TACO) is a major cause of transfusion-related morbidity and mortality in countries with well developed transfusion services. The International Society of Blood Transfusion, the International Haemovigilance Network, and AABB (formerly American Association of Blood Banks), have developed and validated a revised definition of TACO.
METHODS METHODS
International Haemovigilance Network-member haemovigilance systems (Australia, Austria, Denmark, Finland, Greece, India, Ireland, Italy, Japan, Malta, Netherlands, New Zealand, Norway, Slovenia, United Kingdom and United States) provided cases of respiratory complications categorised by their systems, including clinical parameters listed in the 2017 draft definition (part 1). Individual transfusion professionals were then invited to assess 24 case descriptions according to the draft definition (part 2). Positive and negative agreement and inter-rater agreement (κ) were calculated. Based on validation results, cases were reanalysed and slight adjustments made to yield the final 2018 TACO definition.
FINDINGS RESULTS
In part 1, 16 (44%) of 36 haemovigilance systems provided 178 cases, including 126 TACO cases. By use of the 2018 definition, 96 (76%) of 126 cases of TACO were in positive agreement. 19 (37%) of 52 cases were recognised as non-TACO respiratory complications. In part 2 (47 experts from 20 countries), moderate all-case agreement (κ=0·43) and TACO-specific agreement (κ=0·54) were observed. Excluding cases missing some clinical information (eg, N terminal pro-brain natriuretic peptide, distinctive chest x-ray findings, and relationship with existing respiratory co-morbidities like pneumonia and chronic obstructive pulmonary disease) improved all-case agreement to κ=0·50 (moderate) and κ=0·65 (good) for TACO cases.
INTERPRETATION CONCLUSIONS
The two-part validation exercise showed that the revised 2018 TACO surveillance case definition captures 76% of cases endorsed as TACO by participating haemovigilance systems. This definition can become the basis for internationally consistent surveillance reporting and contribute towards increased awareness and mitigation of TACO. Further research will require reporting more complete clinical information to haemovigilance systems and should focus on improved distinction between TACO and other transfusion respiratory complications.
FUNDING BACKGROUND
International Society of Blood Transfusion, International Haemovigilance Network, and AABB.

Identifiants

pubmed: 31080132
pii: S2352-3026(19)30080-8
doi: 10.1016/S2352-3026(19)30080-8
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e350-e358

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Johanna C Wiersum-Osselton (JC)

Transfusion and Transplantation Reactions in Patients Hemovigilance and Biovigilance Office, Leiden, Netherlands.

Barbee Whitaker (B)

Office of Biostatistics and Epidemiology, US Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA.

Sharran Grey (S)

Bolton National Health Service Foundation Trust, Greater Manchester, UK; Serious Hazards of Transfusion, Manchester Blood Centre, Manchester, UK.

Kevin Land (K)

Vitalant, Tempe, AZ, USA.

Gabriela Perez (G)

Department of Research, AABB, Bethesda, MD, USA.

Srijana Rajbhandary (S)

Department of Research, AABB, Bethesda, MD, USA. Electronic address: srajbhandary@aabb.org.

Chester Andrzejewski (C)

System Blood Banking and Transfusion/Apheresis Medicine Services, Department of Pathology, University of Massachusetts Medical School-Baystate, Baystate Health/Baystate Medical Center, Springfield, MA, USA.

Paula Bolton-Maggs (P)

Serious Hazards of Transfusion, Manchester Blood Centre, Manchester, UK.

Harriet Lucero (H)

The Christie National Health Service Foundation Trust, Manchester, UK.

Philippe Renaudier (P)

Service d'Hématologie, Hôpital Pierre Zobda-Quitman, Fort-de-France, Cedex, Martinique.

Pierre Robillard (P)

Héma-Québec, Saint-Laurent, QC, Canada.

Matilde Santos (M)

Instituto Português de Sangue e da Transplantação, Lisbon, Portugal.

Martin Schipperus (M)

Transfusion and Transplantation Reactions in Patients Hemovigilance and Biovigilance Office, Leiden, Netherlands; Haga Teaching Hospital, Leyweg, The Hague, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH